Chiari malformation type 1 is a heterogeneous disease characterized by cerebellar tonsillar herniation through the foramen magnum. Symptomatology is diverse, and diagnosis and treatment are controversial. Some evidence suggests the presence of a genetic component to the disease. However, the specific genetic factors involved remain relatively unknown. Previous reviews have broadly addressed different aspects (clinical manifestations, anatomical trails, treatment) of CM-1 by itself or compared it with other types of Chiari malformation. In this mini-review, we focus our attention on the heterogeneity of this disease and its impact on the study of the genetic etiology of classic CM-1. Patient stratification strategies and endophenotypes definitions are offered to help overcome the heterogeneity.
Chiari malformation type 1
Chiari malformation type 1 (CM-1) is the most prevalent form of the "Chiari malformations", and is characterized by a downward herniation of the caudal part of the cerebellum through the foramen magnum into the upper cervical region ( Figure 1 ). It is a very heterogeneous disease whose current diagnosis relies on an imaging observation of cerebellar tonsil herniation (TH) of at least 3-5mm below the foramen magnum 1, 2 . This TH is usually attributed to a reduced size of the posterior cranial fossa (PCF) (classic CM-1), although other mechanisms may be involved (see below). That is, the subsequent smaller cranial space leads to overcrowded neural structures and the herniation of the cerebellum through the foramen magnum. This results in a direct compression of the neural tissue at the craniovertebral junction and, often, cerebrospinal fluid (CSF) disturbances (decreased velocity and elevated impedance), that can cause other related conditions such as syringomyelia or secondary hydrocephalus 3, 4 . CM-1 is quite heterogeneous with respect to symptomatology, epidemiology and treatment. The symptomatology presented by CM-1 patients is diverse, and its severity does not correlate with the degree of TH, with some asymptomatic cases presenting with prominent TH 3, 5 . The onset of symptoms generally develops gradually, however, trauma, coughing/sneezing or pregnancy can also precipitate the event 3, 6, 7 . The incidence, prevalence and distribution of CM-1 is still unclear, and estimations vary depending on the criteria used to characterize the disease: TH criterion alone, TH criterion accompanied by symptomatology or a defining mechanism of the TH. For example, in the United States (US), almost 1 % of normal adults undergoing MRI scanning have at least 5mm of TH but only about 0.01-0.04 % of adults demonstrate symptoms of CM-1 8 . Epidemiological data from other countries is generally missing. Moreover, in the US, estimates of the prevalence based on specific subtypes and/or comorbid conditions are scarce. Thus, the true prevalence of the condition, with respect to all forms of clinical heterogeneity is unknown. The treatment varies depending on the etiology of the TH. Indeed, in classic CM-1 it also depends on the severity of symptoms, the degree of TH and the presence of other conditions (i.e. syringomyelia or scoliosis). The most common treatment for these patients is surgical PCF decompression (alone or with duraplasty), although cerebellar tonsillectomy, cervical laminectomy, suboccipital cranioplasty are also applied 9, 10 . The goal of these surgical procedures is to decompress the foramen magnum and increase the subarachnoid space in order to avoid the impaction of the cerebellar tonsils, reestablish the CSF flow and reverse the symptoms. However, there is still not a consensus about the best procedure to follow, since not all surgeries result in improvement of symptoms and often more than one surgery is required 8 .
The presence of multiplex families with several CM-1 cases, the co-occurrence of CM-1 in monozygotic twins and the co-inheritance with known genetic syndromes (Table 1 ) strongly argue for a genetic contribution to CM-1 pathogenicity 11 . Despite this evidence, the precise genetic variants causative of the disease remain elusive in most cases. Several genetic studies, using different approaches (mutational analysis, whole genome linkage analysis, genetic association, expression analysis) have been performed in order to attempt to identify the genetic traits underlying this disease [11] [12] [13] [14] [15] [16] . This work has resulted in the implication of several chromosomal regions and a number of candidate genes (Table 2 ). However, it is important to highlight that the major findings were achieved when the CM-1 population was stratified and analyzed in more homogenous clinical groups.
Strategies to consider in future genetic studies of CM-1
In a heterogeneous condition like CM-1, it is essential to properly characterize the patients, not only to establish a good diagnosis, but also to decide the best treatment to follow and to perform studies that help to improve the etiologic knowledge of the disease. Although TH is widely used in the diagnosis of CM-1, it is not heritable or completely correlated with symptomatic disease 12, 16 . Since TH seems to be secondary in CM-1, other factors should be considered in order to successfully identify the genetic etiology of CM-1.
TH mechanism
As mentioned above, it has been generally assumed that TH was a consequence of a hypoplasic PCF due to a shortening of the occipital bone caused by an insufficiency during paraxial mesoderm development 17 . However, other cranial constriction mechanisms, such as premature closure of the cranial sutures (craniosynostosis), can also produce a reduced PCF with a smaller occipital bone; in addition, the reduced PCF is not the only explanation for the origin of TH. Other mechanisms such as cranial settling, occipitoatlantoaxial joint instability, spinal cord tethering, intracranial hypertension and intraspinal hypotension, can lead to TH 18 . For some of these mechanisms, different causal genetic pathways have been described. For example, craniosynostosis with TH (OMIM: #101200, #304110, #123500, #101600, #182212) can be produced by mutations in the FGFR1, FGFR2, EFNB1 and SKI genes; and connective tissue disorders with TH (OMIM: #601776, #615539, #609192, #610168, #613795, #615582, #154700) have been associated with mutations in the DSE, CHST14, TGFBR1, TGFBR2, SMAD3, TGFB3 and FBN1 genes. In classic CM-1, most candidate genes have been related to the different stages of occipital bone development, including the paraxial mesoderm development, somite and sclerotome formation, chondrogenesis and osteogenesis (Table 2) 13, 15, 16, 19, 20 .
Stratifying according to the TH mechanism (presence or absence of history of connective tissue disorders), Markunas et al. observed that the evidence for genetic linkage in several chromosomal regions increased significantly and led to the identification of two missense mutations with incomplete penetrance in the GDF6 gene in two independent classic CM-1 families 14 ( Table 2) .
PCF MRI-morphometric traits as endophenotypes
Although TH herniation is not heritable 12, 16 , other PCF traits are, and the use of these heritable traits are more likely to aid in the identification of the underlying genes.
PCF morphometric characteristics are different in CM-1 patients according to the mechanism of TH 18 . In addition, although a hyploplastic PCF is a common trait for classic CM-1 patients, the regions of the PCF are not equally affected 16, 13, 20 . Usually the PCF is shallower, as a result of the shorter occipital bone, and often the slope of the clivus is reduced, resulting in a predisposition to platybasia. Most studies demonstrated the basilar part of the occipital bone (basioccipital) or clivus (when the sphenoccipital synchondrosis is not visible) is significantly reduced 6, 21, 22 . However, for some cohorts this reduction seems to be more significant in the supraoccipital part 23, 24 , or present for both regions 4 . There are also conflicting reports about the magnitude of the tentorium angle in patients compared to control cohorts 3, 22 (Figure 1 ).
Since the formation and development of the occipital bone is intricate, a morphometric analysis of the PCF based on MRI is essential in classic CM-1 patients. Depending on which part of the occipital bone is abnormal (shorter and/ or present with different slope), the genes involved may be different. The occipital bone is formed from the fusion of the first four somites. However, the parts of these somites that resegment to form the sclerotomes are different for each part 
Age of symptom onset
Traditionally, CM-1 has been considered an adult form of the Chiari malformations since the onset of the symptoms usually occurs during the second or third decade of life. More recently, because of the increased use of MRI diagnosis and clinical awareness, this perception is changing, with an increasing number of pediatric cases being reported 10, 28, 29 . Both pediatric and adult CM-1 patients have TH in common. However, the symptomatology, comorbidities and gender proportion are not exactly the same. For example, and although the precise estimate is still unknown, in adults a higher incidence is generally observed for females, while in pediatric cases this incidence is more evenly distributed among sexes 3, 10, 13, 18, 19, 30 .These differences could indicate that pediatric and adult onset cases are different forms of the disease. There are many examples of other diseases where age of onset is important. In Alzheimer disease, different genetic variants are involved in the early (younger than 65 years old) and late onset forms of the disease 31 .
Gender
The fact that in CM-1 adult form is more common in females, suggests the possibility of sexual-dimorphism. Gender effects can manifest in the presentation of the disease, associated symptoms, prevalence, or age of onset. These differences are also seen in CM-1 as we have described above. Sexual-dimorphism has been observed in other complex human diseases such as cardiovascular disease, asthma, autoimmune diseases, some neurological and psychiatric disorders, as well as some common birth defects and cancers 32 . Many complex human diseases exhibit sex and age differences in gene expression where common variants may alter gene expression and influence disease susceptibility or its progression 33 . For CM-1, the alteration in the occipital bone could be produced at different developmental time points, from embryonic stages until the completion of bone development. Importantly, hormones (parathyroid hormone, growth hormone), including sexual hormones (estrogen, testosterone), are involved in bone growth 34 . Interestingly, some disorders that co-occur with CM-1 are caused by endocrine alterations (Table 1) .
Conclusion
In conclusion, there remains little known about the genetic component involved in the etiology of CM-1. There is a tremendous need to replicate the published studies and validate the findings in independent cohorts, as well as to consider the effect of these stratification strategies on proposed candidate genes. We also cannot discard other genomic mechanisms, such as regulatory variation and epigenetic modifications, as additional contributors to disease etiology.
Thus, other genomic approaches may be needed, such as of the bone 25 . The basilar part fuses with the basisphenoid bone at the sphenoocipital synchondrosis (which derives from neural crests cells and the mesoderm, and its closure finishes at the age of 20 years) 8 ; but the boundaries of the supraoccipital part are given by the interparietalsupraoccipital, lamboid and occipito-mastoid sutures 8, 26 . In addition, the occipital bone has both membranous and cartilaginous types of ossification, and the number of ossification centers for each part is different 8, 26 .
After considering the PCF traits presented in CM-1 patients, Urbizu et al. identified four genetic variants (located in the genes ALDH1A2, CDX1 and FLT1) to be associated with adult classic CM-1, and two of them also associated with the slope of the clivus 31 ( Table 2 ). Using MRI endophenotypes defining two different "shapes" of PCF, Markunas et al. identified different levels of expression in genes related with dorso-ventral axis formation (ETS1, ETS2, NOTCH4), ribosome, spliceosome and proteasome in pediatric classic CM-1 patients 16 ( Table 2 ). These initial findings support the complex genetic basis of the PCF development, and the genetic heterogeneity of CM-1.
Co-occurrence with other genetic disorders
Another approach to identifying genes for CM-1 is to stratify CM-1 according to co-occurring genetic disorders, either by syndrome or according to the associated clinical anomalies (skeletal, hematologic, ophthalmic, endocrine, exocrine, dermatologic, neurologic or immune) (Table  1) . Importantly, some of these different disorders may be related since: 1) they are caused by the same gene/locus (i.e. mutations in GNAS gene have been identified in patients with acromegaly and Pseudohypoparathyroidism type 1A), 2) some of these genes interact (i.e. CREBBP and EP300 are genes that cause Rubenstein-Taybi syndrome, and are involved in chondrocyte differentiation; they interact with LHX4 which is associated with severe combined pituitary hormone deficiency, also described in CM-1 patients), and 3) some of these genes are in the same pathway (i.e. Noonan syndrome and Neurofibromatosis type 1 are caused by alterations in Ras pathway genes).
Familial or sporadic forms of CM-1
The majority of CM-1 cases are believed to be sporadic. However, familial cases (presenting autosomal recessive and autosomal dominant inheritance with incomplete penetrance) have also been reported 12 . Thus, it is possible that the presence or absence of family history is associated with different genes and disease pathogenesis. For example, in some diseases such as Fronto Temporal Dementia or Amyothropic Lateral Sclerosis, different genes, and even different pathways, are affected depending if the cases are familial or sporadic 27 . The fact that some CM-1 families present different inheritance patterns also suggests that there is more than one gene involved in the disease. epigenetic analyses and next generation sequencing, which have not yet been applied to CM-1. Ultimately, however, a better understanding of meaningful clinical stratifications will be required to identify more genetically homogeneous subsets in order to find the causative genetic variants.
